Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024312 (
lymphopenia
)
4,859
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Beta-arrestin 2 has been shown to participate in the pathogenesis of asthma by inducing Th2 cell migration to the lungs. Whether
beta-arrestin 2
regulates cytokine production of CD4+ T cells is still unknown. The aim of the present study was to investigate the effect of
beta-arrestin 2
on the cytokine production of CD4+ T lymphocytes and the mechanism involved in a mouse model for asthma. After silencing
beta-arrestin 2
expression in CD4+ T lymphocytes from asthmatic mice by RNA interference (RNAi), the interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) levels in CD4+ T lymphocyte culture supernatants with or without terbutaline stimulation were determined. Cell-surface beta2 adrenergic receptor (beta2AR) as well as GATA3 expression of CD4+ T lymphocytes were also measured. CD4+ T lymphocytes of mice with allergic asthma expressed higher levels of
beta-arrestin 2
on both mRNA and protein levels.
beta-arrestin 2
RNAi decreased IL-4 (43.16%) and GATA3 (protein 77.21%, mRNA 62.98%) expression after terbutaline stimulation. Cell-surface beta2AR of CD4+ T
lymphocytes decreased
(15.27%) after terbutaline treatment, but recovered after
beta-arrestin 2
RNAi down-modulation. These findings demonstrate that
beta-arrestin 2
regulates IL-4 production and GATA3 expression of CD4+ T lymphocytes partly through the beta2AR signaling pathway in an allergic asthma model.
...
PMID:Effects of beta-arrestin 2 on cytokine production of CD4+ T lymphocytes of mice with allergic asthma. 2187 Apr 26